Copyright Reports & Markets. All rights reserved.

Global Cytotherapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Cytotherapy
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cytotherapy by Type
    • 1.3.1 Overview: Global Cytotherapy Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cytotherapy Consumption Value Market Share by Type in 2023
    • 1.3.3 Stem Cell
    • 1.3.4 Non-Stem Cell
  • 1.4 Global Cytotherapy Market by Application
    • 1.4.1 Overview: Global Cytotherapy Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Cytotherapy Market Size & Forecast
  • 1.6 Global Cytotherapy Market Size and Forecast by Region
    • 1.6.1 Global Cytotherapy Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cytotherapy Market Size by Region, (2019-2030)
    • 1.6.3 North America Cytotherapy Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cytotherapy Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cytotherapy Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cytotherapy Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Cytotherapy Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Gilead Sciences
    • 2.1.1 Gilead Sciences Details
    • 2.1.2 Gilead Sciences Major Business
    • 2.1.3 Gilead Sciences Cytotherapy Product and Solutions
    • 2.1.4 Gilead Sciences Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Gilead Sciences Recent Developments and Future Plans
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Cytotherapy Product and Solutions
    • 2.2.4 Novartis Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments and Future Plans
  • 2.3 Osiris
    • 2.3.1 Osiris Details
    • 2.3.2 Osiris Major Business
    • 2.3.3 Osiris Cytotherapy Product and Solutions
    • 2.3.4 Osiris Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Osiris Recent Developments and Future Plans
  • 2.4 Vericel Corporation
    • 2.4.1 Vericel Corporation Details
    • 2.4.2 Vericel Corporation Major Business
    • 2.4.3 Vericel Corporation Cytotherapy Product and Solutions
    • 2.4.4 Vericel Corporation Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Vericel Corporation Recent Developments and Future Plans
  • 2.5 Vcanbio
    • 2.5.1 Vcanbio Details
    • 2.5.2 Vcanbio Major Business
    • 2.5.3 Vcanbio Cytotherapy Product and Solutions
    • 2.5.4 Vcanbio Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Vcanbio Recent Developments and Future Plans
  • 2.6 Fujifilm Cellular Dynamics
    • 2.6.1 Fujifilm Cellular Dynamics Details
    • 2.6.2 Fujifilm Cellular Dynamics Major Business
    • 2.6.3 Fujifilm Cellular Dynamics Cytotherapy Product and Solutions
    • 2.6.4 Fujifilm Cellular Dynamics Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Fujifilm Cellular Dynamics Recent Developments and Future Plans
  • 2.7 JCR Pharmaceuticals
    • 2.7.1 JCR Pharmaceuticals Details
    • 2.7.2 JCR Pharmaceuticals Major Business
    • 2.7.3 JCR Pharmaceuticals Cytotherapy Product and Solutions
    • 2.7.4 JCR Pharmaceuticals Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 JCR Pharmaceuticals Recent Developments and Future Plans
  • 2.8 Beike Biotechnology
    • 2.8.1 Beike Biotechnology Details
    • 2.8.2 Beike Biotechnology Major Business
    • 2.8.3 Beike Biotechnology Cytotherapy Product and Solutions
    • 2.8.4 Beike Biotechnology Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Beike Biotechnology Recent Developments and Future Plans
  • 2.9 Golden Meditech
    • 2.9.1 Golden Meditech Details
    • 2.9.2 Golden Meditech Major Business
    • 2.9.3 Golden Meditech Cytotherapy Product and Solutions
    • 2.9.4 Golden Meditech Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Golden Meditech Recent Developments and Future Plans
  • 2.10 Guanhao Biotech
    • 2.10.1 Guanhao Biotech Details
    • 2.10.2 Guanhao Biotech Major Business
    • 2.10.3 Guanhao Biotech Cytotherapy Product and Solutions
    • 2.10.4 Guanhao Biotech Cytotherapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Guanhao Biotech Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cytotherapy Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cytotherapy by Company Revenue
    • 3.2.2 Top 3 Cytotherapy Players Market Share in 2023
    • 3.2.3 Top 6 Cytotherapy Players Market Share in 2023
  • 3.3 Cytotherapy Market: Overall Company Footprint Analysis
    • 3.3.1 Cytotherapy Market: Region Footprint
    • 3.3.2 Cytotherapy Market: Company Product Type Footprint
    • 3.3.3 Cytotherapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cytotherapy Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cytotherapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cytotherapy Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cytotherapy Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cytotherapy Consumption Value by Type (2019-2030)
  • 6.2 North America Cytotherapy Consumption Value by Application (2019-2030)
  • 6.3 North America Cytotherapy Market Size by Country
    • 6.3.1 North America Cytotherapy Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cytotherapy Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cytotherapy Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cytotherapy Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cytotherapy Consumption Value by Type (2019-2030)
  • 7.2 Europe Cytotherapy Consumption Value by Application (2019-2030)
  • 7.3 Europe Cytotherapy Market Size by Country
    • 7.3.1 Europe Cytotherapy Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cytotherapy Market Size and Forecast (2019-2030)
    • 7.3.3 France Cytotherapy Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cytotherapy Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cytotherapy Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cytotherapy Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cytotherapy Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cytotherapy Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cytotherapy Market Size by Region
    • 8.3.1 Asia-Pacific Cytotherapy Consumption Value by Region (2019-2030)
    • 8.3.2 China Cytotherapy Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cytotherapy Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cytotherapy Market Size and Forecast (2019-2030)
    • 8.3.5 India Cytotherapy Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cytotherapy Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cytotherapy Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cytotherapy Consumption Value by Type (2019-2030)
  • 9.2 South America Cytotherapy Consumption Value by Application (2019-2030)
  • 9.3 South America Cytotherapy Market Size by Country
    • 9.3.1 South America Cytotherapy Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cytotherapy Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cytotherapy Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cytotherapy Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cytotherapy Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cytotherapy Market Size by Country
    • 10.3.1 Middle East & Africa Cytotherapy Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cytotherapy Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cytotherapy Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cytotherapy Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cytotherapy Market Drivers
  • 11.2 Cytotherapy Market Restraints
  • 11.3 Cytotherapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cytotherapy Industry Chain
  • 12.2 Cytotherapy Upstream Analysis
  • 12.3 Cytotherapy Midstream Analysis
  • 12.4 Cytotherapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cytotherapy market size was valued at USD 1587.7 million in 2023 and is forecast to a readjusted size of USD 4829.8 million by 2030 with a CAGR of 17.2% during review period.
    Cytotherapy is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
    The cytotherapy market is driven by the increasing demand for regenerative medicine and cell-based therapies, offering potential treatments for a range of diseases and conditions. Stem cell therapies and other cell-based approaches hold promise for addressing previously untreatable conditions. However, a significant challenge in this market is the need for rigorous clinical trials and regulatory approvals to ensure the safety and efficacy of these therapies. Developing standardized protocols and navigating complex regulatory pathways can be time-consuming and costly. Additionally, the cost of cytotherapy treatments and access to these innovative therapies remain challenges, requiring healthcare systems and insurance providers to address affordability and accessibility issues.
    The Global Info Research report includes an overview of the development of the Cytotherapy industry chain, the market status of Hospitals (Stem Cell, Non-Stem Cell), Clinics (Stem Cell, Non-Stem Cell), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cytotherapy.
    Regionally, the report analyzes the Cytotherapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cytotherapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Cytotherapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cytotherapy industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Stem Cell, Non-Stem Cell).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cytotherapy market.
    Regional Analysis: The report involves examining the Cytotherapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cytotherapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Cytotherapy:
    Company Analysis: Report covers individual Cytotherapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cytotherapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
    Technology Analysis: Report covers specific technologies relevant to Cytotherapy. It assesses the current state, advancements, and potential future developments in Cytotherapy areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cytotherapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Cytotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Stem Cell
    Non-Stem Cell
    Market segment by Application
    Hospitals
    Clinics
    Others
    Market segment by players, this report covers
    Gilead Sciences
    Novartis
    Osiris
    Vericel Corporation
    Vcanbio
    Fujifilm Cellular Dynamics
    JCR Pharmaceuticals
    Beike Biotechnology
    Golden Meditech
    Guanhao Biotech
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Cytotherapy product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cytotherapy, with revenue, gross margin and global market share of Cytotherapy from 2019 to 2024.
    Chapter 3, the Cytotherapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cytotherapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cytotherapy.
    Chapter 13, to describe Cytotherapy research findings and conclusion.

    Buy now